glp 1 headaches GLP-1 Drug Cuts Migraine Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and chronic migraine. Participants reported an average Common GLP-1 Side Effects and

In August 2025, Eli Lilly (US) announced a collaboration with a leading technology firm to integrate artificial intelligence into its drug development processes

The company also acknowledges on its product page that completing an assessment does not create a clinician-patient relationship with the platform itself

HendersonSJKonkarAHornigoldDCTrevaskisJLJacksonRFritsch FredinMet al

and C.J.H

Key Obesity Drug Stocks and Their 12-Month Performance Novo Nordisk: 60.6% Eli Lilly: 78.1% Pfizer: negative 17.9% Amgen: 44.7% Roche: negative 14.7% Obesity drugs big impact on pharma stocks Amid the obesity epidemic in the United States, pharmaceutical companies have been attempting to develop effective treatments for years

Thats why food choices are so important